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Abstract
The human gut harbors thousands of bacterial taxa. A profusion of metagenomic sequence data has been generated from
human stool samples in the last few years, raising the question of whether more taxa remain to be identified. We assessed
metagenomic data generated by the Human Microbiome Project Consortium to determine if novel taxa remain to be
discovered in stool samples from healthy individuals. To do this, we established a rigorous bioinformatics pipeline that uses
sequence data from multiple platforms (Illumina GAIIX and Roche 454 FLX Titanium) and approaches (whole-genome
shotgun and 16S rDNA amplicons) to validate novel taxa. We applied this approach to stool samples from 11 healthy
subjects collected as part of the Human Microbiome Project. We discovered several low-abundance, novel bacterial taxa,
which span three major phyla in the bacterial tree of life. We determined that these taxa are present in a larger set of Human
Microbiome Project subjects and are found in two sampling sites (Houston and St. Louis). We show that the number of false-
positive novel sequences (primarily chimeric sequences) would have been two orders of magnitude higher than the true
number of novel taxa without validation using multiple datasets, highlighting the importance of establishing rigorous
standards for the identification of novel taxa in metagenomic data. The majority of novel sequences are related to the
recently discovered genus Barnesiella, further encouraging efforts to characterize the members of this genus and to study
their roles in the microbial communities of the gut. A better understanding of the effects of less-abundant bacteria is
important as we seek to understand the complex gut microbiome in healthy individuals and link changes in the microbiome
to disease.
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Introduction
The human gut harbors thousands of bacterial taxa [1], a small
number of which dominate the community [1,2]. Early studies
using sequence-based assays indicated that the majority (62–76%)
of taxa in the gut microbial community are uncharacterized [3,4].
However, many new taxa have been identified in the profusion of
metagenomic sequence data subsequently generated from human
stool samples [2,5–7], raising the question of whether more taxa
remain to be identified. The large number of taxa that occur with
low abundance [1] (Zhou et al, manuscript in preparation)
suggests that there may indeed be rare taxa that remain
unobserved at current sampling depths.
We assessed metagenomic data generated by the Human
Microbiome Project Consortium to determine if novel taxa remain
to be discovered in stool samples from healthy individuals.
Characterizing the full complement of taxa in the human gut is
an important step toward understanding the role of the gut
microbiome in human health and disease. To do this, we
established a rigorous sequencing and bioinformatics pipeline
with sequence data from multiple platforms (Illumina GAIIX and
Roche 454 FLX Titanium) and approaches (whole-genome
shotgun (WGS) and 16S rDNA amplicons). We applied these
techniques to stool samples from 11 healthy subjects collected as
part of the Human Microbiome Project (HMP) [8]. We found
several low-abundance taxa confirmed by multiple datasets.
Results
Datasets and Criteria for Identifying Novel Sequences
Four distinct datasets were used in this analysis (Table 1, Tables
S1 and S2; Figure S1). The first three datasets were derived by
examining stool samples from 8–11 healthy individuals and used
to identify potentially novel sequences. The first and second
datasets (Figure S1A and Table S1) consist of Roche 454 FLX
Titanium sequences from 16S rDNA amplicons from variable
regions 1–3 (Roche V1–3) and 3–5 (Roche V3–5). Together the
sets are referred to as the ‘‘Roche variable regions’’ data. The third
dataset consists of 16S rDNA sequences identified from randomly
sheared, metagenomic DNA fragments that were shotgun-
sequenced on the Roche platform (Roche WGS) (Figure S1B
and Table S1). The final dataset was derived from stool samples
from 94 individuals and was used to validate the potentially novel
sequences. These data consist of 16S rDNA sequences generated
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e35294from both ends of randomly sheared, metagenomic DNA
fragments that were shotgun sequenced on the Illumina platform
and identified as 16S rDNA by alignment to 16S rDNA reference
sets (Illumina WGS) (Figure S1C and Table S2).
We defined novel Roche V1–3, V3–5, and WGS reads as those
that met the following criteria: (1) less than 97% identity to known
16S rDNA sequences in the NCBI NT and the Ribosomal
Database Project (RDP) databases [9,10], and (2) confirmed by
Illumina WGS data, as described below, to ensure that the novel
16S rDNA sequences were not the result of platform bias,
sequencing error or PCR artifact.
Our pipeline for analysis of novel 16S rDNA bacterial
sequences is shown in Figure 1. Identifying novel reads began
with running Roche variable region sequences through Chimera
Slayer [11] and clustering non-chimeric reads at 100% identity to
remove duplicate sequences. 16S rDNA sequences were identified
from the full Roche WGS dataset with PhylOTU [12]. Next, those
reads with ,97% identity to a nearest neighbor in the NCBI NT
and RDP databases were considered potentially novel (see
Methods). Based on this threshold, 4–7% of non-redundant
sequences (4,963 Roche V1–3 reads and 5,210 Roche V3–5 reads)
and about 0.6% (336) of Roche WGS reads identified as 16S
rDNA were potentially novel (Table 1). Finally, we aligned the
Illumina WGS data to the potentially novel Roche WGS and
variable region sequences and used 100% identical alignments to
validate the Roche sequences. The distribution of Illumina WGS
reads across the length of each Roche read was used to identify
sequencing errors and chimeras in the Roche data, as described in
detail below. High-quality Roche WGS and variable region
sequences with Illumina WGS support were considered candidates
for truly novel taxa.
Identifying Novel 16S rDNA Sequences with Data from
Two Sequencing Platforms
Our goal was to identify novel 16S rDNA sequences in the
Roche datasets that were strongly supported by Illumina WGS
sequence data. Given that Roche sequences could be misidentified
as novel because of sequencing error, chimerism (despite having
been screened for chimeras, Figure 1), or real variability from
previously identified bacterial taxa, we distinguished Roche
sequences with real variability from known taxa by analyzing
the alignments of Illumina WGS sequences to the Roche
sequences as follows.
We excluded any Roche variable region or WGS sequences that
were not supported by Illumina WGS reads with perfect
alignments over at least 95% of the length of the Roche sequence
(see Methods for details). We opted for this stringent criterion so as
to identify only the highest confidence reads lacking sequencing
errors that could result in an over-estimation of the number of
novel 16S rDNA sequences. Very rare Roche variable region and
WGS reads might not have been represented in the Illumina WGS
data, and thus were not supported. Application of these criteria
allowed us to narrow our focus to less than 2000 candidate novel
reads (1–3% of non-redundant sequences) for each Roche variable
region dataset and 115 reads (0.2%) for the Roche WGS data
(Table 1).
The alignment patterns of the Illumina WGS sequences to the
Roche data distinguished high-confidence, novel Roche WGS
and variable region sequences from chimeric sequences
(Figure 2B), deletions (Figure 2C) and insertions, uncalled bases
or miscalled bases (Figure 2D). We also removed sequences that
did not have sufficient overlap of aligned Illumina sequences to
confidently confirm the Roche sequence (Figure 2E). These
irregular Roche sequences were revealed by three characteristics
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PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e35294of the Illumina alignments: (1) the maximum length of the
Illumina sequences that align starting at each position within the
Roche sequence gradually decreases and then increases
(Figures 2B–D), (2) Illumina sequences did not overlap each
other significantly (Figures 2B–E), and (3) Illumina paired-end
sequences did not span $90% of the length of the Roche
sequence (Figure 2B–E). These Illumina alignment patterns are
described in detail in the Methods and are graphically depicted
in Figure 2. In the Roche variable region datasets, these
irregularities served as a database-independent method for
detecting chimeric sequences (Figure 2B), and indeed, the
majority of sequence irregularities in Illumina coverage indicated
the presence of a chimeric sequence. Strikingly, this analysis of
the Illumina tiling patterns reduced the number of high-
confidence, novel sequences from about 2000 candidates to 30
high-quality novel Roche V1–3 and 26 Roche V3–5 sequences
in each dataset (Table 1). In the Roche WGS dataset no
chimeric sequences were found, and the reduction in the number
of novel sequences was less severe, resulting in 85 high-quality
novel Roche WGS sequences. Descriptive information about the
novel sequences from each Roche dataset, including RDP
classification and nearest-neighbor descriptions based on align-
ment, is shown in Table S3.
Novel Taxa Found in Amplicon and WGS Datasets
Partially Overlap
The taxonomic distribution of the novel sequences generally
reflects the overall taxonomic structure of stool samples: novel
Firmicutes, Bacteroidetes, and Proteobacteria were identified
(Figure 3). A single read was poorly identified as Actinobacteria
by RDP (bootstrap value of 0.31); the absence of additional novel
taxa within Actinobacteria may simply reflect random sampling of
the very-low-abundance novel taxa.
Several methods were used to compare the novel reads found
from the Roche variable region and WGS datasets. Reads were
taxonomically classified down to the genus level by the RDP
classifier (version 2.2 with training set 6) (Table S3), inserted into
the Silva reference tree (Figure 3), and clustered into operational
taxonomic units (OTUs) by PhylOTU [12](Table S3). The WGS
reads were then aligned against the variable region reads using
NCBI BLAST [13] (details provided in the Text S1).
Overall, the methods agreed (see Text S1 for an explanation
of differences). A large percentage (56%–96%) of novel reads
from each of the three datasets were identified by the RDP
classifier as belonging to the genus Barnesiella, shared significant
sequence identity, clustered into OTUs 12 and 13, and were
placed together on the Silva tree. OTUs 7 and 11, both
identified as belonging to the order Clostridiales, also contain
reads from both the Roche WGS dataset and one of the Roche
variable region datasets. The remaining sequences were distrib-
uted across the major bacterial phyla typically found in stool
samples and produced OTUs with one sequence (OTUs 1–3, 5,
6, 8–10, 14–22), two sequences (OTUs 4,23, 26), or four
sequences (OTUs 24 and 25) from a single dataset (Table S3).
The Most Abundant Novel Taxa Belong to the Genus
Barnesiella
The majority of novel sequences in each dataset were assigned to
the genus Barnesiella (Figure 3, indicated by arrow). In particular, the
two largest OTUs (OTUs 12 and 13) contained reads identified as
Barnesiella or identified with low confidence as a different genus within
the same family or order as Barnesiella. These OTUs have substantial
representation from the Roche WGS data and at least one Roche
variable-region dataset, further validating the observations of these
taxa and indicating that they are sufficiently abundant to be reliably
detected using different sequencing methods. Nonetheless, the
sequences belonging to this OTU included, at most, 1.3% of the
total sequences generated from a single sample. This abundance is
comparable to a rare organism, such as Escherichia coli,w h i c h
comprised a maximum of 0.94% of the sequences in stool samples
from healthy HMP subjects (The Human Microbiome Consortium
(2012) ‘Structure, Function and Diversity of Human Microbiome in
an Adult Reference Population’. Nature: doi:10.1038/nature11234)
(dataset: hmp1.v13.hq.otu.counts, OTU263 classified as Escherich-
ia/Shigella by RDP). Interestingly, the sequences in these two OTUs
are predominantly from a single subject. Both OTUs have support
from multiple visits, indicating that these novel taxa are persistently
present in this individual’s stool. Both OTUs have percent identities
to nearest neighbors and RDP classifications indicating that these
taxa are not vastly divergent from previously observed taxa.
Alignments to cultured Barnesiella are ,90% identical, indicating
that we may have identified novel Barnesiella species or a closely
related genus.
Figure 1. Flow chart describing the pipeline for the identification of novel OTUs. Green circles represent the data collected by the HMP,
with the darkest green circles representing WGS read, and successively lighter green circles associated with 16S reads that show progressively more
evidence of novelty. Blue squares represent external databases used to determine novelty. Major filtering steps in the pipeline are shown as yellow
triangles.
doi:10.1371/journal.pone.0035294.g001
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Level
Novel taxa in human stool samples are not expected to be very
divergent from known taxa because previous studies, particularly
of the 16S rRNA locus, have already captured the major phyla
and classes of gut bacteria. As expected, RDP classifies the
majority of OTUs with confidence at least to an order and nearly
half to a genus (Figure 4B). The two OTUs poorly classified by
RDP at the phylum and order level are examples of reads that are
particularly difficult to classify (since each OTU contains a single
sequence which is less than 200 bp long) and probably do not
represent novelty at a high taxonomic level. Similarly, most novel
OTUs have relatively high percent identity to previously
sequenced 16S rDNA (Figure 4A). We also identified the nearest
neighbor within the set of cultured bacteria (see Methods) to
further assess how divergent the novel taxa are from cultured, well-
characterized bacteria strains. All but two novel sequences were
most similar to uncultured bacteria, and the percent identity to a
nearest neighbor from cultured bacteria is significantly lower than
from uncultured bacteria, on average 4% lower (Figure 4A). The
RDP classification and percent identity to nearest neighbors
indicate that the novel taxa observed are primarily from genera
that have previously been sampled. We observed only a few
sequences that may be novel at the taxonomic level of family or
higher. The most novel OTU by percent identity contains a single
sequence, which has 90.5% identity to its nearest neighbor, but is
still well classified by RDP as the genus Barnesiella (Table S3). The
next most novel OTU is perhaps a better candidate for novelty at
family level or higher, with a single read which has 91.8% identity
to a nearest neighbor, only 85.1% identity to a cultured nearest
neighbor, and confident RDP classification only as low as the
order Clostridiales. While new bacterial phyla may still exist, none
was found in this dataset with our stringent filtering of reads.
Novel Taxa are not Abundant but are Present in Multiple
Individuals
Novel OTUs are generally of low abundance within individuals.
In any one individual, no novel cluster comprised more than 1%
of the total reads in the sample. This indicates that in stool
samples, the abundant bacteria have already been sampled and
deposited into the databases we queried.
To further assess the distribution and abundance of novel
OTUs across a larger set of subjects, sequences from stool samples
from additional healthy subjects collected for the HMP were
screened for the presence of the novel OTUs (see Methods).
Figure 5 shows the distribution of the 26 OTUs in the full set of
Figure 2. Irregularities in Illumina coverage used to identify chimeras and sequencing error. (A) This flow chart describes the removal of
Roche WGS and variable region sequences based on characteristics of the Illumina alignments, resulting in a final set of high-quality novel sequences.
Possible problems listed in red indicate errors in the Roche sequence, and possible problems listed in black indicate situations in which the Roche
read may be of high quality but could not be confirmed by aligned Illumina sequences. The inset plot shows an example of a Roche variable region
sequence with a progressive shortening of aligned Illumina sequences. The base position of the Roche sequence at which the Illumina alignment
begins is plotted on the x-axis, and the maximum length of aligned Illumina reads with the given start position is plotted on the y-axis. In the middle
of the Roche sequence, the Illumina sequences decrease to approximately 60 bp before returning to 100 bp in length. Characteristics of the Illumina
alignments associated with specific problems with the Roche WGS and variable region reads are illustrated in B–D.
doi:10.1371/journal.pone.0035294.g002
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present in multiple subjects (Figure 5B), indicating that these novel
taxa are widespread in the small population sampled. OTUs 17
and 19 are only present in one subject and are each composed of
just one Roche WGS read, suggesting that they were not detected
in additional individuals due to extremely low abundance. OTU
12 contains reads from both the Roche WGS and V3–5 datasets
from multiple samples but only a single individual, indicating that
this OTU is relatively more abundant (although still low) than the
other OTUs, but specific to a single subject. Figure 5B is stratified
by the sampling location of the subjects (St. Louis or Houston).
Most OTUs are split relatively evenly between sampling locations.
However, OTUs 10, 12 and 13 only appear in the Houston cohort
and are all identified as the genus Barnesiella, which could mean
these closely related taxa are specific to or more abundant in the
communities sampled from this region because they are well suited
to the gut environment in this region or population. OTUs 17, 19,
23, and 25 are also only found in the Houston cohort, but this is
likely due to chance sampling of these very-low-abundance OTUs.
Assessment of Primer Bias in the Detection of Novel
Sequences
One reason the Roche WGS and Roche variable region
datasets could differ in the taxa identified is because of the
potential for primer bias in the variable region amplicons. To
assess if novel taxa found only in the Roche WGS dataset
(Figure 5A) were potentially detectable with variable region
sequencing, the novel Roche WGS reads were aligned to the
V1–3, V3–5 and V6–9 primer sequences using NCBI BLAST.
Nearly every novel Roche WGS sequence that overlapped a
priming site had 100% identity to a primer sequence (four
sequences had one or two mismatches with respect to a primer but
likely would still amplify, see Methods). Although the Roche WGS
sequence did not span both primer sites, these data suggest that
differences in the taxa found in the datasets were not due to primer
bias, but rather to random sampling of very-low-abundance taxa.
Primer bias may still limit the novelty observed, but the limitations
may not be apparent due to insufficient sequencing depth or the
effects of the 16S rDNA sequence identification and trimming
Figure 3. Taxonomic distribution of novel reads. Novel reads
from each dataset (dark colored branches, see legend) were inserted
into the Silva reference tree with RAxML and are marked with a red box
at the end of the leaf. Novel reads cluster into phyla that are typically
found in stool samples (light colored branches, as labeled); all
remaining phyla are shown in gray. The black arrow indicates the
group of reads identified as the genus Barnesiella.
doi:10.1371/journal.pone.0035294.g003
Figure 4. Novelty at different taxonomic levels. (A) Distribution of novel OTUs as a function of the maximum percent identity of a constituent
read to a nearest neighbor for (black) all reads in the RDP and NT databases and (red) cultured reads. (B) The distribution of novel OTUs as a function
of the lowest taxonomic rank that was confidently (with a bootstrap value of .0.5) assigned to a constituent read.
doi:10.1371/journal.pone.0035294.g004
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sampling, preparation, storage and DNA extraction could restrict
the novelty observed in both the Roche variable region and WGS
samples.
Discussion
We discovered a number of new bacterial taxa, all but three of
which were represented in multiple subjects from a larger set of
stool samples from over 80 healthy individuals. These findings
establish that bacterial taxa remain to be discovered, even in well-
studied microbial communities such as the healthy human gut. We
also showed that the number of false-positive novel sequences
identified in the 11 samples would have been two orders of
magnitude higher than the true number of novel taxa without
validation by multiple datasets. For example, the discovery of
novel bacterial taxa using metagenomic 16S rDNA sequence data
was complicated by artifacts, such as sequencing errors and
chimerism, which generated false signals of novelty. This study
highlights the importance of establishing rigorous standards for the
identification of novel taxa in metagenomic data. The pipeline we
developed is an important first step towards establishing experi-
mental and bioinformatics criteria for these standards.
Specifically, we found that leveraging Illumina WGS data to
validate potentially novel Roche variable region and WGS 16S
rDNA sequences enabled, with a high level of confidence, the
identification of novel taxa in stool samples from healthy subjects.
The use of independently derived datasets to confirm sequences
allowed us to avoid over-estimating the fraction of novel sequences
within the datasets; instead, we identified a small subset of
sequences that warrant further investigation. Overall, we estimat-
ed that less than 0.07% of high-quality, non-redundant 16S rDNA
sequences are truly novel, based on our strict definition of novel as
sequences that are at most 97% identical to any sequence in public
databases.
The false positives that we eliminated based on our rigorous
validation requirements included sequences that appeared novel
because of chimerism and sequencing errors. Of the 16S rDNA
sequences with less than 97% identity to 16S rDNA reference
sequences, less than 1% of the Roche variable region sequences
were validated while 25% of the Roche WGS sequences were
validated (Table 1). This discrepancy in the percent of reads
validated in each dataset is due to the presence of chimeric
sequences in the Roche variable regions data. The Roche variable
region sequences had been screened for chimeras, but chimeric
sequences were still abundant in the subset of sequences that
appeared to be novel. Of the potentially novel sequences, the
chimeric sequences were the most divergent from a nearest
neighbor and were frequently classified poorly by RDP. Thus, an
analysis of novel sequences without our validation steps would
have grossly overestimated the number of novel sequences and the
taxonomic level at which diversity was found. Sequencing errors
(insertions, deletions, miscalled or uncalled bases) were also a
source of false-positive novel sequences. We did not expect or
detect chimeric sequences in the Roche WGS dataset, and the
false-positive novel sequences in this case were due predominantly
to sequencing errors. While sequencing errors can cause sequences
to appear more divergent from a nearest neighbor, small errors do
Figure 5. Distribution and abundance of novel OTUs. (A) The number of reads assigned to each OTU (x-axis) across all the samples (y-axis) is
represented by color on a scale from light yellow (few sequences) to dark red (many sequences). Within each dataset (‘‘Roche V1–3’’, ‘‘Roche V3–5’’,
and ‘‘WGS’’), samples are organized by their source: the three smaller groups of samples labeled ‘‘11’’ contain the original reads (from 11 subjects)
used to define the OTUs. Reads recruited to the OTUs from the extended Roche variable region datasets (‘‘Roche V3–5’’ and ‘‘Roche V1–3’’) and
Illumina WGS dataset (additional samples, ‘‘AS’’) are also shown. (B) The total number of reads assigned to each OTU (x-axis) across all subjects (y-axis)
is represented by color on the same scale. These data include the original reads as well as reads from both extended variable region datasets and the
Roche and Illumina WGS datasets. The subjects in the lower portion of the figure were sampled in St. Louis while those in the upper portion of the
figure were sampled in Houston.
doi:10.1371/journal.pone.0035294.g005
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with sequencing errors would have slightly inflated our estimation
of novel sequences, but the diversity still would have appeared at
the genus or subgenus level. The artifacts we eliminated by using
Illumina WGS sequences for validation allows us to more
accurately define the degree of novelty and the characteristics of
the novel taxa, including their distribution among individuals,
abundance, and taxonomic classification.
Using the Illumina WGS data to evaluate the Roche variable
region datasets establishes a database-independent method to
detect chimeric sequences. Although the Roche V1–3 and V3–5
sequences had been screened with Chimera Slayer [11], some
chimeric sequences were not identified because Chimera Slayer
(and other database-dependent methods of chimera detection)
only detects chimeras with components that are similar to the
sequences in the reference database [11]. Chimeric sequences can
be very abundant in 16S rDNA amplicon datasets, accounting for
more than half of the diversity in OTUs in some samples [11], and
the same chimera can be formed in independent amplifications of
the same sample [11]. Chimeric 16S rDNA sequences are likely to
be deposited in public databases at a relatively high rate [14].
Chimeric sequences confound 16S rDNA analyses that rely on
accurate sequences for alignment, the generation of distance
matrices and phylogenetic tree construction, and they also inflate
the degree of novelty estimated in bacterial communities. Thus,
novel methods of chimera detection, such as the one presented
here, can improve the analysis of metagenomic data.
While several distinct clusters of reads were found across the
bacterial tree of life, these sequences represent the diminishing
portion of the human gut microbiome that remains unobserved.
Earlier studies estimated that proportion was much higher. The
novel taxa are of relatively low abundance (,1% of the total reads
in a sample), but some are found in multiple individuals (0.5–20%
of individuals at this depth of sequencing), and this recurrence
suggests they are endemic to the human microbiome. Low-
abundance organisms may have important roles in microbial
communities. Dominant organisms in a community can be used to
broadly define microbial habitats in the human body [15] (The
Human Microbiome Consortium (2012) ‘Structure, Function and
Diversity of Human Microbiome in an Adult Reference Popula-
tion’. Nature: doi:10.1038/nature11234) and even microbial
community classes within individuals [2] (Zhou et al, manuscript
in preparation). However, even minor components of bacterial
communities may influence human health [16] or can overgrow
under certain conditions to cause disease [17]. The great diversity
in these low-abundance organisms may allow us to further
distinguish individuals by their bacterial communities or ascribe
functional characteristics related to human health and disease.
We detected novel taxa in the three most prevalent phyla in
stool samples: Bacteroidetes, Firmicutes, and Proteobacteria. Most
of the diversity we detected was at the genus or sub-genus level,
but a few novel 16S rDNA reads were divergent from all other
observed sequences at a higher taxonomic level, potentially as high
as the family level. The novel sequences identified here indicate
that there are undiscovered bacterial taxa. However, the
functional capabilities and other characteristics of these bacteria
remain to be determined by whole-genome sequencing, isolation
and culturing of the organisms, and by studying of the role of these
bacteria within their communities. The novel 16S rDNA
sequences can be used to target specific bacteria for whole-
genome sequencing and will give us insight into what gene
functions these uncharacterized organisms are contributing to the
gut microbial community. Indeed, many of the novel OTUs are
related to organisms that have already been identified by the HMP
reference genome sequencing effort and are sequenced or in the
process of being sequenced (http://www.hmpdacc-resources.org/
hmp_catalog/main.cgi). For example, isolates from Barnesiella,
Desulfovibrio, Dorea and Turicibacter are all included in the collection
of HMP microbial reference genomes.
The two most prevalent novel taxa we detected are in the genus
Barnesiella. OTU 12 was found in a single subject and OTU 13 was
found in eight subjects. These two OTUs were found only in
samples that were collected in Houston, suggesting they may be
suited to bacterial communities related to specific environmental
or dietary factors. Barnesiella was recently discovered in samples
from the chicken gut [18] and in human stool samples [19].
Additional studies are needed to determine the roles of Barnesiella
species in healthy communities and communities affected by diet
or disease.
Some of the other novel taxa we detected in these stool samples
are related to genera associated with shifts in the microbiome
related to diet (Oscillibacter) [20], colorectal adenoma (Dorea) [21],
and opportunistic infections (Desulfovibrio) [22]. More thorough
characterization and whole-genome sequencing of the novel taxa
we identified will be important in order to determine if each of the
novel taxa constitute new families, genera or species and if they
affect or fluctuate with human health conditions.
A better understanding of the effects of bacteria that are less
abundant, less broadly distributed and less well characterized is
important as we seek to understand the complex gut microbiome
in healthy individuals and link changes in the microbiome to
disease. Furthermore, the pipelines and analysis criteria we
developed can be applied to the analysis of novel 16S rDNA
sequences in other microbial communities or habitats, which may
be less well characterized than stool. The HMP has generated
sequence data from samples taken from oral, skin, nasal, and
vaginal body sites in addition to stool, and we anticipate that the
examination of the bacterial communities in those body sites may
reveal diversity that has yet to be appreciated.
Methods
Samples
As part of the HMP initiative [8], subjects provided stool
samples at one, two or three visits, spaced 30 to 359 days apart
(Aargard and Petrosino et al, manuscript submitted). DNA
extracted from each sample (Aargard and Petrosino et al,
manuscript submitted) was sequenced to generate the datasets
described below (The Human Microbiome Consortium (2012)
‘Structure, Function and Diversity of Human Microbiome in an
Adult Reference Population’. Nature: doi:10.1038/nature11234).
All datasets are available from the Short Read Archive (http://
www.ncbi.nlm.nih.gov/sra). Accession numbers are given for
WGS samples in the supplemental materials. Variable region
samples were pooled before sequencing, and the datasets can be
downloaded with the study name ‘‘Human Microbiome Project
16S rRNA 454 Clinical Production Phase I.’’
Whole-genome Shotgun Sequences Sequenced on the
Roche 454 FLX Titanium Platform (Roche WGS 16S)
All available Roche WGS data generated by the Human
Microbiome Consortium were downloaded from the Short Read
Archive (http://www.ncbi.nlm.nih.gov/sra). Data had previously
been processed to remove human sequences. Analysis was limited
to stool samples for which there also existed Roche variable region
data. This yielded 12 samples from 11 individuals; short read
archive identifiers are listed in Table S1. From this dataset, the run
SRR063897 from male subject 686765762 was excluded due to a
Novel Bacterial Taxa in the Human Microbiome
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of the reads in this run as the genera Mobiluncus or Atopobium, taxa
typically associated with the oral and vaginal microbiomes.
The remaining 33,236,142 reads were processed with a
streamlined version of PhylOTU ([12], improvements discussed
below) to identify the 16S sequences and to assess the overall
distribution of the Roche WGS reads into OTUs. PhylOTU
identifies 16S metagenomic reads through a sequence similarity
search against a phylogenetically diverse 16S database (STAP).
Bases from the ends of each read that are not significantly similar
to a database sequence are trimmed from the read to minimize the
inclusion of non-homologous 16S sequence in the subsequent
phylogenetic analysis. Of the input reads, 52,756 ranging from 100
to about 500 bases in length were found to align to the 16S locus
and were processed further. PhylOTU identified 1361 OTUs from
the 16S rDNA sequences, as shown in Figure S2. These 52,756
16S rDNA sequences compose the ‘‘Roche WGS’’ dataset that
was used for the discovery of novel sequences.
Streamlining of PhylOTU
To analyze the Roche WGS dataset, which is approximately
three times the size of the dataset on which PhylOTU was
benchmarked, PhylOTU was modified to more efficiently process
large datasets. Several steps in the PhylOTU workflow were
parallelized and can run on a user specified number of nodes on a
computing cluster. These include the 16S sequence similarity
search, the multiple sequence alignment quality control, and the
construction of a phylogenitic distance matrix. An option was
implemented to use the hcluster function from the ESPRIT
package [23] for the clustering, since it quickly handles clustering a
large number of sequences. These combined improvements
allowed the Roche WGS dataset to be run in approximately 24
hours. This updated version of PhylOTU is available at https://
github.com/sharpton/PhylOTU.
Whole-genome Shotgun Sequences Generated on the
Illumina GAIIX Platform (Illumina WGS 16S)
The Human Microbiome Consortium generated 60–100-base,
paired-end Illumina GAIIX data for 147 stool samples. Data
downloaded from the Short Read Archive had been processed to
trim low-quality sequences, remove duplicate sequences from each
sample, mask low-complexity sequences with Dust [24], and
remove human sequences (The Human Microbiome Consortium
(2012) ‘Structure, Function and Diversity of Human Microbiome
in an Adult Reference Population’. Nature: doi:10.1038/
nature11234). Short-read archive identifiers for the 147 samples
are included in Table S2. Sequences corresponding to bacterial
16S genes were identified by aligning the Illumina WGS sequences
to a database of 16S sequences. Alignments were done using
cross_match [25] with relaxed parameters: -raw -tags -bandwidth
3 -penalty -1 -gap_init -1 -gap_ext -1 -masklevel 101. The
database comprised 12,627 sequences generated by combining the
16S reads from the RDP training set 6 with additional 16S
sequences from completed bacterial genomes found at the Entrez
Genome Project (http://www.ncbi.nlm.nih.gov/sites/
entrez?db=genome) as of August 3, 2010. The 67,679,702 16S
sequences were used for further analysis.
V1–3 and V3–5 16S Variable Region Sequences (Roche
V1–3 and Roche V3–5)
Variable region sequences that were generated on the Roche 454
FLX Titanium platform by the HMP Consortium were downloaded
from the DACC (Version 1.0) (http://www.hmpdacc.org/
resources/data_browser.php) and supplemented with data from
(http://www.hmpdacc.org/resources/data_browser.php). The V1–
3 dataset included 92,330 reads from 178 stool samples from 139
individuals.TheV3–5datasetincluded160,948readsfrom307stool
samples from 208 individuals. Sequences from the V1–3 and V3–5
datasets ranged in length from 200 to 500 bases. The data were
minimally processed to remove PCR primer sequences and tags.
Chimera screening was done using Chimera Slayer [11], and
sequences identified as chimericwere removed from furtheranalysis.
Identification of Potentially Novel Sequences
Samples from 11 subjects were sequenced by three methods:
Roche WGS, Roche targeted 16S variable region, and Illumina
WGS. Novel sequences were identified in this subset of samples,
which included 12 Roche V1–3 samples from eight of the 11
subjects, 20 Roche V3–5 samples from 11 of the 11 subjects, and
12 Roche WGS samples from 11 of the 11 subjects (Table S2) by
the following steps (Figure 1).
Sequences in the Roche V1–3 and V3–5 datasets were clustered
to collapse sequences with 100% identity over 95% of the read
length using cd-hit [26] and a single representative sequence from
each cluster was used in the following. Reads from all three datasets
were aligned to (a) the RDP database (downloaded November 9,
2010 from https://rdp.cme.msu.edu, 1356230 sequences) and (b)
theNTnucleotide database(last validatedwithdownload from June
2011). WU-BLAST was used with default parameters [27].
For the variable region data reads with greater than 97%
identity to a sequence in the RDP or NT database over at least
95% of the sequence length were excluded from further analysis,
and the remaining sequences were novel candidates. At the end of
the analysis pipeline, the nearest neighbor of each novel sequence
with Illumina confirmation was identified as the database sequence
that aligned to the variable region sequence with the highest
bitscore, after requiring the alignment length be at least 100 bp in
length and any unaligned portion of the read be #5b p o r
overhanging the end of the target read.
In the Roche WGS dataset, alignments between a query read
and database target were required to be at least 100 bp in length,
with any unaligned portion of the read being #5 bp in length or
overhanging the end of the target read. Of the target alignments
meeting these criteria, the one with the highest bitscore was chosen
as the nearest neighbor. The Roche WGS reads having a nearest
neighbor with ,97% identity were then aligned to the variable
region primers with NCBI BLAST, using a word size of 7. We
reevaluated those sequences with less than 100 bases of
consecutive non-primer sequence for a nearest neighbor by
relaxing the alignment length from 100 bases to the longest
stretch of non-primer sequence found in the read. This check only
affects short reads of approximately 100 bases by ensuring that
database sequences, which are highly similar to the query except
for the primer sequence (which is often trimmed off sequences
deposited in the databases), would be considered in the nearest-
neighbor search. This also ensures that short reads have high
information content and are not identical to a known sequence
over a large fraction of the read length. Roche variable region and
WGS reads having a nearest neighbor with ,97% identity were
considered potentially novel in the initial analysis.
Validating Novel 16S Sequences from Roche WGS and
Roche V1–3 and V3–5 Datasets with Illumina WGS Reads
Potentially novel sequences were confirmed by aligning the
Illumina WGS sequences from all of the stool samples to the
potentially novel sequences from the Roche variable region
datasets or Roche WGS data with cross_match [25]. For the
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and at least 60 bp in length. The entire length of the Illumina read
was required to align, excluding any portion extending beyond the
end of the Roche WGS read. Only Roche WGS reads that were
covered by aligned Illumina reads over 100% of their length were
retained for further analysis. For the Roche variable region data,
Illumina WGS sequences that aligned with 100% identity over
100% of their length were used to validate the sequences. The
depth and breadth of coverage of the Roche variable region read
with Illumina WGS reads was evaluated using RefCov [28].
Roche variable region reads that were covered by aligned Illumina
WGS reads over greater than 95% of their sequence length were
included for further analysis. The 95% cutoff was used for the
Roche variable region sequences because the sequences had not
been subject to stringent quality trimming and, therefore, might
contain some sequencing error on the ends of the reads.
Illumina sequence coverage of Roche WGS and variable region
sequences was evaluated as follows. We observed two major
irregularities that were indicative of chimerism, miscalled bases,
uncalled bases, insertions, deletions, or insufficient Illumina
coverage. First, for a Roche read with good Illumina support,
the maximum length of the Illumina WGS sequences (60–100
bases in length) that were tiled across the Roche sequence
remained a fairly constant length (.90 bases) at any given
alignment start point (except at the end of the read). In contrast,
the maximum read lengths of the tiled Illumina reads covering a
problematic read gradually decreased until the maximum read
length was #70 bases, only to increase again (Figure 2). Second,
for a Roche read with good Illumina support, a tiling path could
be identified consisting of Illumina sequences that overlapped by
at least 20 bases and extended the coverage by at least 20 bases
(excluding those that aligned at the end of the Roche sequence).
However, this was not true for Roche reads that were problematic
or lacked sufficient Illumina support (Figure 2). The chimeric
sequence analysis included manual evaluation of hundreds of
reads, including the alignment of separate pieces of the reads to
different taxa in 16S rDNA sequence databases. Alignments and
coverage were manually reviewed using Tablet [29].
Potentially novel reads were further evaluated for a third
irregularity in the Illumina coverage using the paired-end feature
(sequences from both ends of the same DNA fragment) of the
Illumina WGS data (Figure 2). Some of the paired sequences should
(1) align to a non-chimeric Roche variable region sequence or high-
quality Roche WGS sequence and (2) span nearly the full length of
the Roche read. Roche sequences that do not have support from
paired-end Illumina reads could be chimeric or have sequencing
errors that prohibit the alignment of one of the mate pairs.
Therefore, the paired-end test provides additional support for a
Roche sequence that shows no other evidence of chimerism or
error. This paired-end test is not informative for all Roche reads, as
only a subset of paired end sequences was expected to span the
length of the Roche variable region and WGS sequences for several
reasons. First,theinsertsizesofIllumina WGSlibraries rangedfrom
100–500 bases, so only those paired reads from a fragment of
approximately the length of the Roche read being examined could
provide support. Furthermore, Roche sequences with few support-
ing Illumina WGS reads, which are likely rare sequences, may not
have paired-end sequences due to the decreased likelihood of
finding paired ends with the right span within the relatively few
aligned Illumina sequences. Therefore, we onlyrequired paired-end
support for those reads with a median depth of Illumina WGS
coverage greater than 500 reads and a length of greater than
200 bp. These reads were only considered high-quality novel
sequencesifasetofIlluminaWGSpairedend readsspannedatleast
90% of the Roche sequence.
Identification of Nearest Neighbors to Novel Reads from
Cultured Bacteria
A nearest neighbor was identified for each novel read from
subset of reads in the databases that were labeled to indicate they
were from a cultured source. Nearest neighbors from these smaller
databases were identified in the same way as above. Alignments
were required to be at least 100 bp in length and any unaligned
portion of the sequence to be #5 bp or overhanging the end of the
target read. The nearest neighbor was chosen as the highest
bitscore alignment meeting these criteria.
For the RDP database, all reads marked as Source:Isolates and
Quality:Good were considered. For the NT database, reads were
excluded based on the sequence description. All sequences with
‘‘uncultured’’ or ‘‘16S rDNA sequence amplified from human
fecal sample’’ in the description were excluded. The descriptions of
nearest-neighbor hits were then manually inspected and those
sequences from uncultured sources were excluded.
Taxonomic Classification of Novel Reads
Novel reads were classified by the RDP Classifier (version 2.2
using training set 6) [30], which assigns reads to taxonomic groups
from the phylum to genus level and generates a bootstrap value,
indicating the confidence of the identification at each taxonomic
level. Where applicable, a bootstrap threshold of 0.5 was used.
Insertion of Novel Sequences into the SILVA Reference
Tree and Tree Visualization
Novel sequences were aligned to the full-length SILVA reference
database with Mothur [31]. The alignments containing the full-
length SILVA reference sequences and novel sequences were
transformed to relaxed PHYLIP format. The novel sequences were
assigned to the SILVA reference tree by EPA [32] using the
maximum-likelihood (ML) method implemented in the RAxML
web-based server [33]. Taxonomy tags indicating the phylum of
each node were added to the tree with a custom Perl script. The
resulting phylogeny was visualized and edited with Archaeopteryx
(version 0.957 beta, http://www.phylosoft.org/archaeopteryx) [34].
Classification of Novel Reads into OTUs
Novel sequences from the Roche variable region and WGS
datasets were clustered using PhylOTU. To eliminate any
trimming of the Roche variable region sequences, the first blast
step of PhylOTU was skipped with the ‘‘–k A’’ option. The 141
novel Roche WGS and variable region sequences were clustered
into 26 operational taxonomic units (OTUs) with PhylOTU
(Table S3). The two largest OTUs (containing 12 and 89
sequences, respectively) contained sequences from both the
Roche WGS and at least one Roche variable region dataset.
The remaining OTUs contained less than six sequences.
Analysis of Primer Sequences in the Roche WGS Novel
Sequences
To address the effects of primer bias on the datasets, we
determined if the reads detected in the Roche WGS dataset could
have been detected with the primers used to produce the variable
region datasets. Aligning the Roche WGS novel sequences (with
NCBI BLAST, using a word size of 7) to the primers used in the
V1–3, V3–5 and V6–9 variable-region sequencing identified 78 of
the 85 reads with 100% identity to one of the primer sequences.
Three reads did not overlap any of the variable region primer sites,
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variable region datasets, indicating that the novel sequences are
within a region that can be amplified. The remaining four reads
had one or two mismatches to a primer, but would likely still
amplify. The Roche WGS dataset did not reveal any obvious
primer bias. However, the identification of 16S rDNA sequences
from the Roche WGS data and the associated trimming may bias
the Roche WGS data sample toward known sequences, so that
novel reads with unique sequence at the priming sites were
excluded from this analysis early in the analysis pipeline.
Distribution of Novel Sequences in an Extended Dataset
In the Roche variable region data, the longest read from each
OTU was chosen as a representative sequence for the OTU. The
representative sequences were clustered with data from 131 and 197
additional subjects (Table S4) for the V1–3 and V3–5 data,
respectively, using cd-hit [26] at a 97% identity threshold. Sequences
co-clustering with the representative sequences were used as an
approximationofthepresenceoftherepresentativenovelsequencein
additional subjects. Roche WGS data were not available from a
substantial number of additional subjects, so we used a different
approach based on Illumina WGS data (147 samples from the 94
subjects represented in the variable region datasets). If an Illumina
WGS sample contained reads validating 100% of a Roche WGS
sequence from a novel OTU, we concluded that the novel OTU was
present in the Illumina sample.These methods yielded a conservative
estimate of the distribution of the novel taxa among individuals.
Supporting Information
Figure S1 Graphical descriptions of datasets.
(TIF)
Figure S2 Distribution of Roche WGS OTUs across
individuals. All Roche WGS reads identified as 16S rDNA were
clustered into 1361 species-level OTUs with PhylOTU. The
fraction of OTUs found in each subject is shown, indicating the
relative diversity of the samples from each subject. ‘‘V1’’ and ‘‘V2’’
indicate two independent visits at which the subject 809635352
was sampled.
(TIF)
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Table S3 Table describing read attributes, nearest
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